Receptor Tyrosine Kinase Inhibitors
DBCAT004052Pharmacologic class
A DrugBank category of 4 drugs. 4 of them are approved.
What you can answer from here — as of September 06, 2018
Which targets do Receptor Tyrosine Kinase Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account